CVSG

CVS Group reports steady sales growth and progress on strategy

CVS reported a 5.7 percent rise in sales and improved adjusted EBITDA for the four months to 31 October 2025, supported by stronger like for like growth and continued membership gains in its Healthy Pet Club scheme...
Search

Funds

Search

Funds

CVSG

FTSE 100

Funds